Company Filing History:
Years Active: 2003-2012
Title: Jurgen Maier: Innovator in Bacterial Adhesion Research
Introduction
Jurgen Maier is a prominent inventor based in Köngen, Germany. He has made significant contributions to the field of molecular biology, particularly in understanding bacterial adhesion mechanisms. His work has implications for developing therapeutic strategies against bacterial infections.
Latest Patents
Jurgen Maier holds 2 patents that focus on nucleic acid molecules encoding proteins that mediate the adhesion of bacteria to human cells. His latest patents describe nucleic acid molecules that encode proteins facilitating the adhesion of bacteria from the genus Neisseria to human cells. These patents also detail the proteins encoded by these nucleic acid molecules and the antibodies directed against them. Furthermore, they encompass pharmaceutical compositions, vaccines, and diagnostic compositions containing these nucleic acid molecules, proteins, and/or antibodies.
Career Highlights
Jurgen Maier is affiliated with the Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., a leading research institution in Germany. His work at this prestigious organization has allowed him to explore innovative solutions to complex biological problems.
Collaborations
Some of Jurgen Maier's notable coworkers include Thomas F. Meyer and Thomas Rudel. Their collaborative efforts have contributed to advancing research in the field of bacterial adhesion and its implications for human health.
Conclusion
Jurgen Maier's innovative research and patents in bacterial adhesion highlight his significant role in the scientific community. His contributions pave the way for future advancements in medical treatments and diagnostics.